OPKO HEALTH, INC.
About OPKO HEALTH, INC.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $606.9M
- Net income
- -$225.7M
- Total assets
- $1.9B
- Market cap
- $1.1B
- Gross margin
- 33.9%
- Operating margin
- -19.3%
- Net margin
- -37.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $606.9M
- Cost of revenue
- $400.9M
- Gross profit
- $205.9M
- Operating expenses
- $323.3M
- Operating income
- -$117.4M
- Income tax
- -$15.7M
- Net income
- -$225.7M
- EPS (basic)
- $-0.30
- EPS (diluted)
- $-0.30
Balance sheet
- Total assets
- $1.9B
- Current assets
- $581.9M
- Total liabilities
- $664.0M
- Current liabilities
- $146.7M
- Shareholders’ equity
- $1.3B
Cash flow
- Operating cash flow
- -$178.5M
- Investing cash flow
- $230.3M
- Financing cash flow
- -$118.1M
- Net cash flow
- -$66.3M
Statements via Polygon.io (SEC filings)
- Market cap
- $1.1B
- EPS (diluted)
- $-0.3
- Shares outstanding
- 760.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 2, 1995
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $225.7M in FY2025.
- Revenue declined 58% from FY2020 to FY2025.
- Gross margin of 33.9%, net margin -37.2%.
- Trading 9% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review OPKO HEALTH, INC..
Write a review
News about OPKO HEALTH, INC.
News & sentiment via Polygon.io
